High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications
Masaru Harada(University of Occupational and Environmental Health Japan), Michio Sata(Kurume University), Takato Ueno(Kurume University), Hiroshi Yoshida(Tokyo National Hospital), Yuko Fujisawa(Kurume University), Masaharu Sakamoto(Kurume University), Kazuhisa Gondo(Yanagawa Rehabilitation Hospital), Takuji Torimura(Omuta hospital), Kurumi Sasatomi(Kurume University), Shotaro Sakisaka(Fukuoka University), Takumi Kawaguchi(Kurume University), Shuji Sumie(Kurume University), Eitaro Taniguchi(Kurume University), Kyuichi Tanikawa(Kurume University), Hironori Koga(Kurume University)
Cited by 65
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504